Relmada Therapeutics, Inc. (RLMD)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
24-Sep-21 10:00 PM
View: 
Casamento Charles J
Director
Relmada Therapeutics, Inc. (RLMD) 22-Sep-21Market Option Sale (Planned) 6,600$29.00$191,400.00(40%)
16.6K to 10.0K
24-Sep-21 10:00 PM
View: 
Casamento Charles J
Director
Relmada Therapeutics, Inc. (RLMD) 22-Sep-21Option Exercise 10,000$4.60$46,000.00152%
6.6K to 16.6K
19-Aug-21 5:00 PM
View: 
Casamento Charles J
Director
Relmada Therapeutics, Inc. (RLMD) 17-Aug-21Option Exercise 10,000$4.60$46,000.00213%
4.7K to 14.7K
16-Jul-21 10:00 PM
View: 
Casamento Charles J
Director
Relmada Therapeutics, Inc. (RLMD) 15-Jul-21Market Sale (Planned) 3,300$31.54$104,088.00(41%)
8.0K to 4.7K
(< 1%)
02-Jun-21 5:00 PM
View: 
Casamento Charles J
Director
Relmada Therapeutics, Inc. (RLMD) 01-Jun-21Market Sale (Planned) 3,000$33.34$100,020.00(30%)
9.95K to 6.95K
3%
05-May-21 5:00 PM
View: 
Casamento Charles J
Director
Relmada Therapeutics, Inc. (RLMD) 03-May-21Market Sale (Planned) 3,000$38.22$114,647.00(23%)
12.95K to 9.95K
< 1%
05-Apr-21 4:08 PM
View: 
Casamento Charles J
Director
Relmada Therapeutics, Inc. (RLMD) 01-Apr-21Market Sale (Planned) 3,000$35.43$106,281.00(19%)
15.95K to 12.95K
(3%)
10-Mar-21 6:18 PM
View: 
Shenouda Maged
CFO
Relmada Therapeutics, Inc. (RLMD) 10-Mar-21Market Option Sale (Planned) 2,373$35.11$83,313.40(52%)
4.6K to 2.23K
11-Mar-21 5:51 PM
View: 
Traversa Sergio
CEO
Director
Relmada Therapeutics, Inc. (RLMD) 10-Mar-21Market Option Sale 2,983$35.09$104,676.00(3%)
91.76K to 88.77K
11-Mar-21 5:51 PM
View: 
Traversa Sergio
CEO
Director
Relmada Therapeutics, Inc. (RLMD) 09-Mar-21Option Exercise 10,000$3.24$32,400.0011%
88.77K to 98.77K
11-Mar-21 5:50 PM
View: 
Kelly Paul Edward
Director
Relmada Therapeutics, Inc. (RLMD) 09-Mar-21Option Exercise 5,000$3.24$16,200.003%
167.29K to 172.29K
11-Mar-21 5:51 PM
View: 
Traversa Sergio
CEO
Director
Relmada Therapeutics, Inc. (RLMD) 09-Mar-21Market Option Sale 7,017$35.65$250,169.00(7%)
98.77K to 91.76K
11-Mar-21 5:50 PM
View: 
Kelly Paul Edward
Director
Relmada Therapeutics, Inc. (RLMD) 09-Mar-21Market Option Sale 5,000$35.71$178,551.00(3%)
172.29K to 167.29K
10-Mar-21 6:18 PM
View: 
Shenouda Maged
CFO
Relmada Therapeutics, Inc. (RLMD) 09-Mar-21Market Option Sale (Planned) 7,527$35.56$267,693.00(62%)
12.13K to 4.6K
10-Mar-21 6:18 PM
View: 
Shenouda Maged
CFO
Relmada Therapeutics, Inc. (RLMD) 08-Mar-21Option Exercise 10,000$3.24$32,400.00449%
2.23K to 12.23K
10-Mar-21 6:18 PM
View: 
Shenouda Maged
CFO
Relmada Therapeutics, Inc. (RLMD) 08-Mar-21Market Option Sale (Planned) 100$35.00$3,500.00(< 1%)
12.23K to 12.13K
02-Mar-21 4:08 PM
View: 
Casamento Charles J
Director
Relmada Therapeutics, Inc. (RLMD) 01-Mar-21Market Sale (Planned) 3,000$33.87$101,618.00(16%)
18.95K to 15.95K
< 1%
26-Feb-21 4:48 PM
View: 
Shenouda Maged
CFO
Relmada Therapeutics, Inc. (RLMD) 24-Feb-21Option Exercise 3,000$3.24$9,720.00135%
2.23K to 5.23K
26-Feb-21 4:48 PM
View: 
Shenouda Maged
CFO
Relmada Therapeutics, Inc. (RLMD) 24-Feb-21Market Option Sale (Planned) 3,000$34.18$102,529.00(57%)
5.23K to 2.23K
26-Feb-21 4:49 PM
View: 
Kelly Paul Edward
Director
Relmada Therapeutics, Inc. (RLMD) 24-Feb-21Market Option Sale 5,000$34.19$170,933.00(3%)
172.29K to 167.29K
26-Feb-21 4:50 PM
View: 
Traversa Sergio
CEO
Director
Relmada Therapeutics, Inc. (RLMD) 24-Feb-21Option Exercise 10,000$3.24$32,400.0011%
88.77K to 98.77K
26-Feb-21 4:49 PM
View: 
Kelly Paul Edward
Director
Relmada Therapeutics, Inc. (RLMD) 24-Feb-21Option Exercise 5,000$3.24$16,200.003%
167.29K to 172.29K
26-Feb-21 4:50 PM
View: 
Traversa Sergio
CEO
Director
Relmada Therapeutics, Inc. (RLMD) 24-Feb-21Market Option Sale 10,000$34.24$342,392.00(10%)
98.77K to 88.77K
17-Feb-21 6:37 PM
View: 
Kelly Paul Edward
Director
Relmada Therapeutics, Inc. (RLMD) 16-Feb-21Option Exercise 5,000$6.00$30,000.003%
162.29K to 167.29K
16-Feb-21 5:10 PM
View: 
Traversa Sergio
CEO
Director
Relmada Therapeutics, Inc. (RLMD) 11-Feb-21Option Exercise 1,446$3.24$4,685.042%
88.77K to 90.22K
16-Feb-21 5:10 PM
View: 
Traversa Sergio
CEO
Director
Relmada Therapeutics, Inc. (RLMD) 11-Feb-21Market Option Sale 1,446$35.43$51,238.40(2%)
90.22K to 88.77K
16-Feb-21 5:08 PM
View: 
Shenouda Maged
CFO
Relmada Therapeutics, Inc. (RLMD) 11-Feb-21Option Exercise 1,428$3.24$4,626.7264%
2.23K to 3.66K
16-Feb-21 5:08 PM
View: 
Shenouda Maged
CFO
Relmada Therapeutics, Inc. (RLMD) 11-Feb-21Market Option Sale (Planned) 1,428$35.39$50,542.10(39%)
3.66K to 2.23K
10-Feb-21 7:25 PM
View: 
Traversa Sergio
CEO
Director
Relmada Therapeutics, Inc. (RLMD) 10-Feb-21Market Option Sale 1,930$35.28$68,097.20(2%)
90.7K to 88.77K
10-Feb-21 7:25 PM
View: 
Shenouda Maged
CFO
Relmada Therapeutics, Inc. (RLMD) 10-Feb-21Market Option Sale (Planned) 2,410$35.20$84,825.50(52%)
4.64K to 2.23K
10-Feb-21 7:25 PM
View: 
Kelly Paul Edward
Director
Relmada Therapeutics, Inc. (RLMD) 09-Feb-21Market Option Sale 2,069$35.28$73,004.70(1%)
164.36K to 162.29K
10-Feb-21 7:25 PM
View: 
Shenouda Maged
CFO
Relmada Therapeutics, Inc. (RLMD) 09-Feb-21Market Option Sale (Planned) 5,359$35.24$188,843.00(54%)
10.0K to 4.64K
10-Feb-21 7:25 PM
View: 
Traversa Sergio
CEO
Director
Relmada Therapeutics, Inc. (RLMD) 09-Feb-21Market Option Sale 5,963$35.21$209,939.00(6%)
96.67K to 90.7K
10-Feb-21 7:25 PM
View: 
Traversa Sergio
CEO
Director
Relmada Therapeutics, Inc. (RLMD) 08-Feb-21Option Exercise 11,206$3.24$36,307.4013%
88.77K to 99.98K
10-Feb-21 7:25 PM
View: 
Kelly Paul Edward
Director
Relmada Therapeutics, Inc. (RLMD) 08-Feb-21Option Exercise 3,569$3.24$11,563.602%
162.29K to 165.86K
10-Feb-21 7:25 PM
View: 
Shenouda Maged
CFO
Relmada Therapeutics, Inc. (RLMD) 08-Feb-21Option Exercise 11,372$3.24$36,845.30510%
2.23K to 13.6K
10-Feb-21 7:25 PM
View: 
Traversa Sergio
CEO
Director
Relmada Therapeutics, Inc. (RLMD) 08-Feb-21Market Option Sale 3,313$35.03$116,049.00(3%)
99.98K to 96.67K
10-Feb-21 7:25 PM
View: 
Kelly Paul Edward
Director
Relmada Therapeutics, Inc. (RLMD) 08-Feb-21Market Option Sale 1,500$35.04$52,559.90(< 1%)
165.86K to 164.36K
10-Feb-21 7:25 PM
View: 
Shenouda Maged
CFO
Relmada Therapeutics, Inc. (RLMD) 08-Feb-21Market Option Sale (Planned) 3,603$35.04$126,242.00(26%)
13.6K to 10.0K
04-Feb-21 5:40 PM
View: 
Traversa Sergio
CEO
Director
Relmada Therapeutics, Inc. (RLMD) 03-Feb-21Market Option Sale 100$35.00$3,500.00(< 1%)
88.97K to 88.87K
04-Feb-21 5:38 PM
View: 
Shenouda Maged
CFO
Relmada Therapeutics, Inc. (RLMD) 03-Feb-21Market Option Sale (Planned) 100$35.00$3,500.00(4%)
2.33K to 2.23K
04-Feb-21 5:38 PM
View: 
Shenouda Maged
CFO
Relmada Therapeutics, Inc. (RLMD) 02-Feb-21Option Exercise 3,200$3.24$10,368.00144%
2.23K to 5.43K
04-Feb-21 5:38 PM
View: 
Shenouda Maged
CFO
Relmada Therapeutics, Inc. (RLMD) 02-Feb-21Market Option Sale (Planned) 3,100$35.04$108,634.00(57%)
5.43K to 2.33K
03-Feb-21 6:34 PM
View: 
Kelly Paul Edward
Director
Relmada Therapeutics, Inc. (RLMD) 02-Feb-21Market Option Sale 2,315$35.04$81,117.60(1%)
164.61K to 162.29K
04-Feb-21 5:40 PM
View: 
Traversa Sergio
CEO
Director
Relmada Therapeutics, Inc. (RLMD) 02-Feb-21Option Exercise 3,278$3.24$10,620.704%
88.77K to 92.05K
04-Feb-21 5:42 PM
View: 
Traversa Sergio
CEO
Director
Relmada Therapeutics, Inc. (RLMD) 02-Feb-21Option Exercise 13,281$3.24$43,030.4018%
75.49K to 88.77K
04-Feb-21 5:40 PM
View: 
Traversa Sergio
CEO
Director
Relmada Therapeutics, Inc. (RLMD) 02-Feb-21Market Option Sale 3,178$35.08$111,470.00(3%)
92.05K to 88.87K
03-Feb-21 6:34 PM
View: 
Kelly Paul Edward
Director
Relmada Therapeutics, Inc. (RLMD) 01-Feb-21Market Option Sale 31$35.00$1,085.00(< 1%)
164.64K to 164.61K
02-Feb-21 5:05 PM
View: 
Casamento Charles J
Director
Relmada Therapeutics, Inc. (RLMD) 01-Feb-21Market Sale (Planned) 3,000$33.63$100,898.00(14%)
21.95K to 18.95K
(4%)
03-Feb-21 6:34 PM
View: 
Kelly Paul Edward
Director
Relmada Therapeutics, Inc. (RLMD) 01-Feb-21Option Exercise 17,346$3.24$56,201.0012%
147.29K to 164.64K